Post-genome, Celera now shoots for profits.
B
B
O'Keefe
D001709:Biotechnology / Q000191:economics*; D004345:Drug Industry / Q000191:economics*; D016045:Human Genome Project; D006801:Humans; D007449:Investments; D008396:Maryland; D017422:Sequence Analysis, DNA